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Abstract
1. When the various anticancer agents are injected intravenously to normal rabbits and in-
traperitoneally to normal mice, it seems that the serum properdin levels fall transitorily for some
hours after administration with a small dose and then keep rising, but with a massive dose it contin-
ues to fall from the beginning. 2. The properdin level is decreased considerably by Thio-TEPA and
Carzinophilin; moderately by Mitomycin C; and slightly by M. H. OX-substance hardly changes
the level and 8-azaguanine rather has a tendency to raise the level. 3. The administration of most
anticancer agents seems to suppress the properdin system. 4. The influence of these agents on
human serum properdin is similar to that of rabbits. 5. The properdin levels keep at high titers in
the group to which the agents act effectively on the cancer, but the levels fall down more rapidly
and animals die earlier in the group to which the agents act ineffectively on the cancer as compared
with the control group.
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In Part II it was found that properdin system, one important factor of host
natural immunity, can be one barrier against cancer and it changes in an
inverse proportion to the aggravation of tumors.
One of the greatest difficulties in the treatment of malignant tumor lies in
its metastasis. Recently it has become clear that cancer cells are in the blood
stream of cancer patients1.2.:J.4.5, sometimes these cells flow into the blood
stream in such a great population as to be called canceremia, and it is an unde-
niable fact that cancer cells in the blood are responsible for metastasis or metas-
tatic recurrence. This fact indicates that surgical operations and X-ray radiation
have reached a certain limit. Since cancer is not only localized but spread all
over the body, it is natural that we seek much from chemotherapy of cancer.
The chemotherapy has yielded but little satisfactory results, so that the natural
resistance to cancer in the host should be re-evaluated in order to stamp out
cancer. Against the most widely supported theory that cancer starts as a lo-
calized disease, it spreads with the lapse of time to the regional lymphnodes,
and eventually throughout the body, there is another theory called by Ian MacDONALD~ "biologic predeterminism" that each cancer has certain biologic cha-
racteristics which tend to stay at more or less definite state througout its life.
In the latter theory it is the type of cancer and the resistance of the host rather
than time that largely determines the spread of cancer. Gerald O. McDoNALD'
went so far as to declare that host resistance is an important key to the cure of
cancer.
If anticancer agents should greatly decrease the host natural resistance
without much injury to cancer cells, they act in reality as the cancer-growth
stimulants. Accordingly, when we administer various kinds of anticancer agents
to healthy or cancer bearing individuals, it is of utmost importance to find out
what effect they will have on the properdin system.
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MATERIALS AND METHODS
The experimental animals used were comparatively young adult rabbits,
weighing approximately 2 kg, and mature female Cb strain mice, weighing
about 20 g. The experimental tumors transplanted were Brown-Pearce car-
cinoma for rabbits and Ehrlich ascitic carcinoma for mice.
Brown-Pearce carcinoma was transplanted into the liver of rabbits throughportal vein and in mice, 7-10 day old Ehrlich ascites was aseptically implanted
into the peritoneal cavity, as was described in Part lI.
The anticancer agents used were as follows:
As anticancer antibiotics, Mitomycin C, Carzinophilin and Sarkomycin.
As anticancer chemicals, 8-azaguanine, Thio-TEPA (Triethylene thiopho-
sphoramide) and M. H. (mercury complex salt of hematoporphyrin).
As an anticancer physical agent, OX-substance (a highly unsaturated fatty
acid which was extracted by YAMAMOTO from the bone marrow and liver of
the rabbit after the total body X-irradiation).
All the anticancer agents were injected into the marginal veins of rabbit
ear on one side and blood sample was taken periodically from the veins of the
contralateral ear, and in the mice the agents were intraperitoneally injected andblood was taken from 3 or 4 mice of each group by cardiac puncture periodical-
ly before and after the injection. In man the anticancer agents were intraveno-
usly administered to cancer patients before operation and blood was collectedfrom the elbow vein.
The separated sera were stored at - 30°C in the sealed tubes till the com-pletion of the blood collection in a series.
Properdin levels of all the samples were measured at least within a month
after the blood collection.
The method of the properdin assay, Rp and R3 used for this assay were
previously described.
RESULTS
A. Influences of several anticancer agents upon serum properdinlevels in normal condition.
1. Influences of several anticancer agents upon serum properdinlevels in normal rabbits.
Groups of 3 rabbits each were used.
Group I. The group to which Mitomycin C was administered.
a. The group to which 1 mg/kg Mitomycin C was administered once.
Mitomycin C was injected in the dilution of 5 ml with saline solution. Three
hours after the injection the properdin level rather fell, 2-3 days later it tended
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Fig. 1. Mean effect of a single injection of Mitomycin C (lmg/kg) on
the properdin levels in rabbits.
to rise and 1-2 weeks later reverted to the value before injection (Fig. 1).
b. The group administered with (1 mg/kg) Mitomycin C for 7 days suc-
cessively. The properdin le~el fell after the first injection and later gradually
rose and reached its peak (150%) on the fifth day, and suddenly fell after that(Fig. 2). Two rabbits died, one on the ninth and the other on the tenth day,
respectively. The tendency of the rise in the properdin level was not indicatedin one surviving rabbit after one week.
c. The group administered with 2 mg/kg Mitomycin C successively.
Three hours after the first injection the properdin level rather fell, but after 24
hours suddenly it rose to over 170 per cent of the value before injection and
suddenly fell after that, and finally fell to 50 per cent on the third day. Two
rabbits died, one on the fourth and the other on the fifth day, respectively (Fig.
3). Pr.~n
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Fig. 3. Mean effect of multiple injections
of Mitomycin C (2mg/kg) on the
properdin levels in rabbits.
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Fig. 2. Mean effect of 7 injections
of Mitomycin C (lmg/kg) on the
properdin levels in rabbits.
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d. The groups administered with Mitomycin C 0.5 mg/kg and 0.1 mg/kg
successively for 7 days. No rabbit died in the two groups. About 3 days after
the first administration the properdin level reached its peak and fell afterwards.
It showed a tendency to recover after the seventh injection, but 2-3 weeks later
it still remained at rather a low level (Fig. 4).
e. The groups administered with Mitomycin C 0.5 mg/kg and 0.1 mg/kg
for 11 days. It was much the same as in group d, but it did not show any ten-
dency of rising in 2-3 weeks after injection (Fig. 5). No rabbit died.
Mitomycin C
0.5 mg/kg
It O.lmg/kg140
160
-eo
120
100
days
e-e : Mitomycin C 0.5mg;kg
0-0 : 11 O.lmg/kg
Fig. 4. Mean effect of 7 injections of
Mitomycin C (0.5mg/kg; O.lmg/kg)
on the properdin levels in rabbits.
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Fig. 5. Mean effect of 11 injections of
Mitomycin C (0.5mg/kg; O.lmg/kg)
on the properdin levels in rabbits.
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Group 11. The group administered with Carzinophilin.
a. The group administered successively with 25 rlkg Carzinophilin.
Carzinophilin was injected in the dilution of 5 ml with saline solution.
Three hours after the first injection the properdin level rapidly fell to 50 per
cent of the level before administration anp. changed through subsequent injections,
generally continuing to fall (Fig. 6). One rabbit out of three died of lack of
appetite and emaciation on the fifth day. As the two remaining indicated the
sign of emaciation, the injection was stopped after five injections.
b. The group administered successively with 5 r/kg Carzinophilin for 7 days.
None indicated the sign of lack of appetite and debility in this group.
Three hours after the first injection the properdin level fell to approximately
two thirds of the level before injection, and stayed at low level for 2 or 3 days
after that, and a week after the seventh injection it reverted to only two thirds
of the original level (Fig. 7).
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Fig 7. Mean effect of 7 injections
of Carzinophilin (5')' /kg) on the
properdin levels in rabbits.
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Fig. 6. Mean effect of multiple injections
of Carzinophilin (2S')'/kg) on the
properdin levels in rabbits.
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c. The group administered with 5 rlkg Carzinophilin for 11 days.
It was the same as in group b, but a week after the completion of injection
the properdin level did not tend to rise. No rabbit died in this group (Fig. 8).
Group Ill. The group administered successively with 35 mg/ kg 8-
azaguanine for 7 days.
8-azaguanine was injected in the dilution of 5 ml with saline. Three hours
after the first injection the properdin level fell to approximately 60 per cent of
the value before injection, but in 24 hours it showed a higher level than the
original, and it gradually decreased afterwards, but 24 hours after the seventh
injection it showed approximately the same level as before administration and
showed the tendency of rising after that (Fig. 9). No change was seen in thegeneral conditions of the rabbits.
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Fig. 8. Mean effect of 11 injections of
Carzinophilin (S')'/kg) on the
properdin levels in rabbits.
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Fig. 9. Mean effect of 7 injections of
8-azaguanine (35 mg/kg) on the
properdin levels in rabbits.
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Group IV. The group administered with Thio·TEPA.
a. The group administered successively with 4 mg/kg Thio-TEPA.
Five ml of Thio-TEPA diluted with saline was injected at a time. With
repeated injections the properdin level kept falling, and when it fell to approx-
imately 40 per cent of the original level, one of the three rabbits died (Fig. 10).
After the fourth injection three rabbits languished so that injection was discon-
tinued.
b. The group administered with 2 mg/kg Thio-TEPA successively for 7days.
Three hours after the first i~jection the properdin level did not fall, but
rather rose and later fell and showed the lowest value 3-5 days later. In a
week after the injection was finished, the properdin level stayed at rather lower
level than before (Fig. 11).
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Fig. 10. Mean effect of multiple
injections of Thio·TEPA
(4mgjkg) on the properdin
levels in rabbits.
Fig. 11. Mean effect of 7 injections
of Thio-TEPA (2mgjkg) on. the
properdin levels in mbbits.
Group V. The group adn'}inistered with M. H.
a. The group administered successively with 10 mg/kg M. H.
M. H. was dissolved with 5 % glucose solution and 5 ml of it was injected
at a time. Three hours after the first injection the properdin level fell to two
thirds of the level before injection and rose or fell to some extent since then,
and on the fourth day one of three rabbits died, and two remaining ones on the
sixth day with copious bloody diarrhea. Owing to the severe debility of the total
body of the rabbits the injection was discontinued after five injections (Fig. 12).
b. The group administered successively with 2 mg/kg M. H. for 7 days.
Three hours after the first injection the properdin level did not show a fall
but inversely a transitory rise. Twenty-four hours after the seventh injection
the level was rather lower than that before injection, after 3~4 days it reverted
to the level before injection, but later rather tended to rise (Fig. 13).
6
Acta Medica Okayama, Vol. 15 [1961], Iss. 1, Art. 5
http://escholarship.lib.okayama-u.ac.jp/amo/vol15/iss1/5
Pr."
100 hBD
r.n
Serum Properdin and Cancer 65
o
T days
Fi~. 12. Mean effect of multiple injectionR
of M. H. (lOmg/kg) on the
properdin levels in rabbits.
Fig. 13. Mean effect of 7 injections
of M. H. (2mg/kg) on the
properdin levels in rabbits.
Group VI. The group administered successively with 20 mg/kg OX-
substance for 7 days.
Five ml of OX-substance diluted with saline was injected at a time. Four
to five days after the first injection, the properdin level tended to rise to some
extent but the changes were insignificant (Fig. 14).
Control group. The groups to which Physiological saline solution 5
ml/rabbit and 5 % glucose solution 5 ml/ rabbit were administered suc-
cessively for 7 days.
In all cases there was no perceptible change of the properdin le'~/el (Fig. 15).
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Fig. 14. Mean effect of 7 injections of OX-substance
(20mg/kg) on the properdin levels in rabbits.
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Fig. 15. Mean effect of 7 injections of physiological saline
solution (5 ml/rabbit) and of 596 glucose solution (5ml/rabbit)
on the properdin levels in rabbits.
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2. Influences of administering several anticancer agents upon
serum properdin levels in man.
As anticancer agents can not be administered to normal persons, they are
administered to cancer patients before operation and chang~. in the properdin
value are followed. Accordingly, the examination of the level through a long
period after administration is not possible. In the cases of intravenous injection
of 10 mg Mitomycin C for 4 days, 50r Carzinophilin for 7 days, 3 g Sarkomycin
for 7 days, and 15 mg Thio-TEPA for 7 days respectively; similar phenomena
were observed as in the cases of rabbits as in Figure 16. a-d. In the case of
administration of 100 mg OX-substance for 7 days, no change was found in the
properdin levels as in the case of rabbits (Fig. 16. e). With 70 mg 8-azaguanine
for 3 days, it tended to rise higher than the level before injection (Fig. 16. f).
Comment: 1. When the substances that combine with properdin in vitro are
administered to experimental animals intravenously, it seems that these substances
interact with properdin in vivo and change their properdin levels. Immediately
after these substances are injected, the serum properdin level falls to low levels,
but reverts to more than normal values within 2-3 daysR,fl,lO. LANDY, et at.ll
injected bacterial lipopolysaccharides into the peritoneal cavity of a mouse and
showed that properdin level was changed two or three hours after injection. As
for the time and dose relation in the case of injection of 100 p.g, the properdin
level fell in ]2-24 hours and later showed notable rise lasting for at least 5
days. In the case of injection of 10 !lg, the level rose in only 6 hours and in 24
hours reached double the value before injection, and lasted for 72 hours, and this
elevation occurred without the prior fall in the properdin level. They inferred
that this might, therefore, be_due to a direct stimulation of the synthesis or
release of properdin ~ath~r than to a mechanism which represents overcompensa-
tion Hrebound" on the part of the host. In the case of 1 !lg, it was the same as
in the case of 10 !.lg. In the case of O.l!lg it was the same as in the case of the
injection of saline solution. HOFF12 saw that the change in the properdin system
was nonspecific and was found in the cases of impulse of central nervous system
and artificial fever, and that in artificial fever in man the properdin level showed
the lowest value in the third hour when the fever reached its peak after the in-
jection of pyrogene lipopolysaccharide and 1-2 days later it rose to approxi-
mately double the value before injection.
The relation between the administration of anticancer agents and the serum
properdin level can not be understood because there are still such unsolved pro-
blems as whether or not anticancer agents combine with properdin in vivo, how
long anticancer agents remain in blood stream after administration, what
organs or cells of living beings are injured by anticancer agents, where properdin
is produced, and the adequate dose, time, and frequency of administration of
8
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Fig. 16. a. Effect of 4 injections
of Mitomycin C 10 mg on the
properdin levels in man.
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Fig. 16. b. Effect of 7 injections
of Carzinophilin 50')' on the
properdin levels in man.
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Fig. 16. c. Effect of 7 injections
of Sarkomycin 3 g on the
properdin levels in man.
Fig. 16. d. Effect of 7 lnJections
of Thio-TEPA 15mg on the
properdin levels in man.
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Eig. 16. e. Effect of 7 Injections
of OX-substance 100mg on the
properdin levels in man.
Eig. 16. f. Effect of 3 Injections
of 8-azaguanine 70 mg on the
properdin levels in man.
9
Orita: Studies on relationship between serum properdin and cancer III
Produced by The Berkeley Electronic Press, 1961
68 K. ORITA
anticancer agents. Accordingly, it is not always justified to attach too much
importance to the relation between the two, but it seems that properdin falls
transitorily for some hours after administration of a small dose and then keeps on
rising, hut it keeps falling from the first in the case of administering a massive
dose. It is very difficult to evaluate precisely the effect of each anticancer agents
as the dose administered differs in each case, but it seems that Thio-TEPA and
Carzinophilin lower properdin levels considerably; Mitomycin C, moderately;
and M. H. slightly; that OX-substance hardly changes the levels as in the case
of administration of saline and glucose solution, and that 8-azaguanine rather
tends to raise its levels. We must await future investigations to see by what
mechanisms these anticancer agents lower the properdin levels or interfer with
properdin zymosan assay, but these agents seem to have undesirable effects
upon the properdin system which is an important factor of host natural resis-
tance.
2. It is uncertain whether anticancer agents have the same effect upon a
normal person as upon a cancer patient, but it can be assumed that anticancer
agents have a considerable effect upon human serum properdin levels.
B. Influences of administering anticancer agents upon serum pro-
perdin levels in cancer bearing animals.
1. Experimental studies by Ehrlich ascitic carcinoma in mice.
When anticancer agents are administered to experimental animals, time
from the tumor implantation to its first administration, methods, frequency and
the amount of administration are important factors. As it is said that the cancer
cell division reaches its peak in 3 days and 5 days after implantation, the
administration of anticancer agents was started in 48 hours after implantation.
Several anticancer agents were intraperitoneally injected once a day for 7 days
in succession.
Group I. The group administered with IOr/mouse Mitomycin C for
7 days.
a. The group of normal mice administered with Mitomycin C. The pro-
perdin level rather fell after the first injection and later rose. When the seventh
injection was finished, it reverted to the level before administration (Fig. - 17).
b. The group of ascitic cancer bearing mice administered with Mitomycin C.
The weight of mice did not increase in about 15 days after implantation and
its abdomen did not swell, but in 20 days they began to die of cancer. Fifty per
cent of them survived for 28 days, untreated control group survived for 12 days.
As in Fig. 18, the properdin level in this case showed between that of the
control group and that of the group of normal mice administered with Mitomycin
C, and 20 days after implantation, the properdin level was a little over 40 per
10
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Fig. 17. Mean effect of 7 injections of Mitomycin C (10,>, /mouse), of Carzinophilin
(I'>' /mouse) and of Thio-TEPA (90'>' /mouse) on the properdin levels in normal mice.
0-0 : Mean effect of 7 injections of Mitomycin
C (10'>' /mouse) on the properdin levels in
ascitic cancer bearing mice.
•-. : Progerdin levels in untreated ascitic cancer
bearing mice.,
-----0
20 ~--.._--
Fig. 18.
cent than that before implantation. Five out of 24 mice survived for more than
100 days and in their postmortem examination, no ascites and tumor metastasis
could be seen.
Group 11. The group administered with 1 r/mouse Carzinophilin
for 7 days.
a. The group of normal mice treated with Carzinophilin.
The properdin level gradually fell after the fi~st injection, and down to the
lowest level after the third injection, and reverted to the normal level in about
14 days after the seventh injection. Its weight rather tended to decrease (Fig. 17).
b. The group of ascitic cancer bearing mice treated with Carzinophilin.
In 3-6 days after implantation the properdin level suddenly fell in the
same way as in the untreated control groups. Later the level gradually rose and
reverted to that before implantation in about 20 days. They began to die in 3
weeks and 50 per cent of them survived for 35 days and the level began to fall
again in the terminal period. In control group 50 per cent survived for 13 days.
Four out of 22 cases were completely cured. In 8 cases out of those which died,
11
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their weights ranged 25-30 g, and the storage of a considerable amount of
hemorrhagic ascites could be seen, and in 10 cases there was a marked decrease
in weight, but ascites and tumor metastasis could not be seen (Fig. 19).
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Fig. 19.
0-0 : Mean effect of 7 injections of Carzinophilin (1"1 /mouse)
on the properdin levels in ascitic cancer bearing mice.
.-. : Properdin levels in untreated ascitic cancer bearing mice.
Group Ill. The group treated with 90r mouse Thio-TEPA/or 7days.
a. The group of normal mice treated with Thio-TEPA.
The properdin level gradually fell after the first administration, and it
stayed at rather low level a week after the seventh injection (Fig. 17).
b. The group of ascitic cancer bearing mice treated with Thio-TEPA.
The fall in its properdin level and the increase in its weight were controlled
to some extent as compared with the untreated control group. All of the 20
cases died within 14-24 days after implantation. Fifty per cent of them sur-
vived for 18 days, while the control group survived for 13 days (Fig. 20).
Group IV. The group treated with 2.5mg/mouse Sarkomycin for
7 days.
a. The group of normal mice treated with Sarkomycin.
The properdin level fell after the first administration and later rose and
indicated the highest level for 1-4 days and later fell (Fig. 21).
b. The group of ascitic cancer bearing mice treated with Sarkomycin.
The properdin level was the mean value between the value of untreated
control grou'p and that of normal mice treated with Sarkomycin and remained
at a high level for a long time as compared with the control group. Fifty per
cent of them survived for 20 days, while the control group survived for 16 days.
All 15 animals died within 14-25 days after implantation (Fig. 22).
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.-0: Mean effect of 7 injections of Thio-
TEPA (90 "Y / mouse) on the pro-
perdin levels in ascitic cancer
hearing mice.
.-. : Properdin levels in untreated ascitic
cancer bearing mice.
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Fig. 21. Me<.ln effect of 7 injL'Ctions of
Sarkomycin (2.5 mg/mouse) on the
properdin levels in normal mice (.-.)
and Sarkomycin (0.25 mg/mouse) on
the properdin levels in normal mice
(0-0)
Group V. The group treated with 0.25 mg/mouse Sarkomycin for
7 days.
a. The group of normal mice treated with Sarkomycin.
The properdin level rose after the first injection, but it fell to four fifths of
the level before injection in about 7 days after the seventh injection (Fig. 21).
b. The group of ascitic cancer bearing mice treated with Sarkomycin.
The increase in the weight and the storage of ascites were more rapid and
so was the fall in the properdin level as compared with the control group. All of
Pt."
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Fig. 22.
0- 0 : Mean effect of 7 injections of Sarkomycin
(2.5 mg/mouse) on the properdin levels
in ascitic cancer bearing mice.
•-. : Properdin levels in untreated ascitic cancer
bearing mice.
Fig. 23.
0-0 : Mean effect of 7 injections of
Sarkomycin (0.25mg/mouse) on the
properdin levels in ascitic cancer
bearing mice.
.-. : Properdin levels in untreated ascitic
cancer bearing mice.
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the 15 mice died of tumor within 8-17 days after implantation. Fifty per cent
of them survived for 14 days, while the control group survived for 16 days.
When 0.25 mgjmouse Sarkomycin was administered, it rather stimulated
cancer growth (Fig. 23).
2. Experimental studies Brown- Pearce carcinoma in rabbits.
The group treated- with 35 mgj kg 8·azaguanine for 7 days after
transplantation.
The injection of 8-azaguanine into the vein of the ear was started 72 hours
after implantation into the liver through portal vein. In control group, 5 ml of
physiological saline was injected in the same way for 7 days.
The properdin level was kept at a little higher level than in the controlgroup, but 3 rabbits died, one 13 days, another 16 days, and the last 18 days
after transplantation, respectively, while in the control group one rabbit died in
14 days and 2 rabbits in 16 days. No effect of 8-azaguanine could be recognized(Fig. 24).
Pr.% •
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Fig. 24.
Cl-Cl: Mean effect of 7 injections of
8-azaguanine (35 mg/kg) on the
properdin levels in cancer bearing
rabbits.
•-. : Properdin levels in untreated
cancer bearing rabbits.
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OMMENT
The same experiment as before with rabbi~ was attempted by using several
kinds of anticancer agents. Though these agents are hitherto reported tu act
against uther malignant tumor effectively, it has been clarified in the present
experiment that they are hardly effective against Brown-Pearce carcinoma of
rabbit. Therefore, Ehrlich ascitic carcinoma of mice were chiefly employed.
When anticancer agents act effectively as observed in the group treated withCarzinophilin and Mitomycin C, the properdin levels are kept for a lung time at
a higher level than that of the control group. In such instances the properdinlevel seems to change in inverse proportion to the spread of cancer cells. The
properdin levels fell lower and fifty per cent of mice died earlier in the group
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treated with 0.25 rImouse Sarkomycin than the control, and it seems to suggest
that, unless anticancer agents are properly selected for administration, they
might stimulate cancer-growth.
Taking the effect of surgical procedure on the host into consideration, it is
found that, besides the surgical injury of local tissues, the cells of the liver,
the bone marrow and the brain are injured owing to general anesthesia, reduc-
tion in blood pressure and anoxia, etc. Chemicals13 which promote the growth
of tissues are mobilized to these injured spots, and these chemicals, together
with the decrease in the resistance of these spots, make cancer cells that are
scattered in a great number into the blood stream or the lymphatic stream or in
the operated region, prone to be implanted to these injured spots. In this con-
nection there are many reports by BEAHRSI4, VINKI(" COLE1G and many others.
On the other hand, it has been explained experimentally that the general anes-
thesia '7, absorption of necrotic products of tissuelll •1fl, bleedingro.21 , and the in-
crease of cortisone22.~1 following surgical operation, decrease the host resistance
against the growth of cancer, but the actual causes are not yet clear. It was
described in Part II that the serum properdin level stayed at a low level for a
long period after operation in the extended radical operation for gastric cancer.
Furthermore, it was explained both experimentally and clinically that, if anti-
cancer agents are administered to living beings, it has undesirable effects upon
its properdin. Since cancer is not a local disease but is prone to spread all over
1:xx1y, it is a matter of course that anticancer agents should be administered.
Under unfavorable conditions where many cancer cells are evolved in the blood
stream after operation, and the host natural resistance is decreased both locally
and totally, unless anticancer agents are administered with consideration to its
quality and quantity, they will rather enhance the recurrence and metastasis of
cancer. When an improper amount of Sarkomycin was administered to cancer
bearing mice, it was found that the growth of cancer was promoted and the
properdin level fell more rapidly than that of the contrd~. SHEAR'2~ inferred that
the formation of metastasis after removing primary focus was probably caused
by the break in the balance between cancer and the properdin system of the
host. VINK15 injected suspension of Brow-Pearce carcimoma cells into the small
intestines of rabbits, resected the intestines and then reanastomosed it. He re-
ported that the frequency of recurrence at the anastomosed part in the group
treated with Sulphasuxidine and Streptomycin were four times higher than that
of the untreated group. This fact seems to have some bearing upon properdin
system. Conversely, as was seen in cancer-bearing mice, if the choice of anti-
cancer agents is proper, the properdin level is kept high and the effect of treat-
ment is great. All these facts make us realize the impartance of the host
natural defense mechanism against cancer, and, moreover, tell us how carefully
15
Orita: Studies on relationship between serum properdin and cancer III
Produced by The Berkeley Electronic Press, 1961
74 K. ORITA
anticancer agents must be chosen and how important and urgent it is to establish
the reliable screening test for anticancer agents. At the present stage where we
still have many unsolved problems about the host resistance against cancer, we
have to continue to expand surgical procedures and need not to hesitate to
perform radical operation for cancer, but if we take into consideration the fact
that metastatic lesions can be found in the distant part from primary focus in
necropsy25 even after radical operation for cancer and that cancer cells of the so-
called "ruhende metastase"26 or "premetastatische phase"27 begin to grow by
surgical manipulation, it seems to be reasonable that surgical operation of
suitable extent should be chosen to each cancer patient. In treating cancer
patients all the care and cosideration be given before we decide for surgical ope~
ration and or chemotherapy.
CONCLUSIONS
1. When the various anticancer agents are injected intravenously to normal
rabbits and intraperitoneally to normal mice, it seems that the serum properdin
levels fall transitorily for some hours after administration with a small dose and
then keep rising, but with a massive dose it continues to fall from the beginn-ing.
2. The properdin level is decreased considerably by Thio-TEPA and Car-
zinophilin; moderately by Mitomycin C; and slightly by M. H. OX-substance
hardly changes the level and 8-azaguanine rather has a tendency to raise thelevel.
3. The administration of most anticancer agents seems to suppress the pro-perdin system.
4. The influence of these agents on human serum properdin is similar to
that of rabbits.
5. The properdin levels keep at high titers in the group to which the agents
act effectively on the cancer, but the levels fall down more rapidly and animals
die earlier in the group to which the agents act ineffectively on the cancer as
compared with the control group.
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